Prescription drug · UNAPPROVED DRUG OTHER
NP Thyroid 30 NDC 68071-3690
levothyroxine, liothyronine · Levothyroxine 19 ug/1; Liothyronine 4.5 ug/1 · Tablet · Oral · NuCare Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68071-3690-3 | 68071369003 | 30 TABLET in 1 BOTTLE (68071-3690-3)Marketed from Sep 27, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- NP Thyroid 30
- Generic name (nonproprietary)
- levothyroxine, liothyronine
- Active ingredients
- Levothyroxine — 19 ug/1Liothyronine — 4.5 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- NuCare Pharmaceuticals,Inc.
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Thyroxine (Chemical structure)Triiodothyronine (Chemical structure)
- Identifiers
- Product ID 68071-3690_231da938-51ac-cb47-e063-6394a90a0766SPL ID 231da938-51ac-cb47-e063-6394a90a0766SPL set ID 231da0d9-b9b6-5201-e063-6394a90a78c6RxCUI 313387, 1724439UNII Q51BO43MG4, 06LU7C9H1VUPC 0368071369038
- Pharmacologic class
- l-Thyroxine; l-Triiodothyronine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468071369003followed by a unit qualifier and the quantityPackage 68071-3690-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE: NP Thyroid® tablets (thyroid tablets, USP) are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WA…
Excerpt only. Read the full label for complete information.